|
Title |
Association between comorbid conditions and disease severity in COVID-19 patients: A retrospective study from a government medical college hospital of Central India
|
|
Authors |
Rakesh Kumar Sisodia1, Tarunendra Kumar Mishra1,*, Mahesh Kumar Patidar2 & Mahendra Chouhan1 & Umesh Sinha3
|
|
Affiliation |
1Department of General Medicine, Government Medical College Ratlam, Madhya Pradesh, India; 2Department of Respiratory Medicine, Government Medical College Ratlam, Madhya Pradesh, India; 3Department of Community Medicine, Government Medical College Ratlam, Madhya Pradesh, India; *Corresponding author
|
|
|
Rakesh Kumar Sisodia - E-mail: dr.r.k.sisodia17@gmail.com; Phone: +91 9993506558 Tarunendra Kumar Mishra - E-mail: mishratarunendra@yahoo.com; Phone: +91 9584715516 Mahesh Kumar Patidar - E-mail: dr.mahesh7patidar@gmail.com; Phone: +91 9977999416 Mahendra Chouhan - E-mail: drmahendrachouhan@gmail.com; Phone: +91 7997227411 Umesh Sinha - E-mail: umi_sinha@yahoo.com; Phone: +91 9826036279
|
|
Article Type |
Research Article
|
|
Date |
Received June 1, 2026; Revised
June 30, 2026; Accepted June 30, 2026, Published June 30, 2026 |
|
Abstract |
The COVID-19 pandemic has posed a major global health challenge, with emerging evidence showing worse outcomes among patients with pre-existing comorbidities. Therefore, it is of interest to examine the association between comorbidity status and disease severity among 384 laboratory-confirmed COVID-19 patients admitted to a government medical college in Central India. Patients were divided into comorbid (n=192) and non-comorbid (n=192) groups, with hypertension (69.27%), diabetes mellitus (36.98%) and cardiac disease (13.54%) being most prevalent. Fever (67.45%), cough (55.47%) and shortness of breath (36.20%) were predominant symptoms, while severe illness occurred in 29.69% of comorbid versus 11.46% of non-comorbid patients (χ²=24.83, p<0.00001). Thus, we show that hypertension and diabetes markedly increase COVID-19 severity, emphasizing prioritized care and aggressive management of high-risk populations.
|
|
Keywords |
Coronavirus disease 2019 (COVID-19), comorbidities, disease severity, hypertension, diabetes mellitus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
|
|
Citation |
Sisodia et al. Bioinformation 22(6): 3640-3646 (2026)
|
|
Edited by |
Vini Mehta
|
|
ISSN |
0973-2063
|
|
Publisher |
|
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|
|
|